Overview
Phoenix Pharma Polska provides logistics services for the pharmaceutical sector, including distribution, transport and importer warehouse operations. The company operates manufacturer wholesalers, provides sales support and offers product repackaging as part of deliveries across Europe.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2026.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 792.8KPLN 792,848 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Sep 22, 2014 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Trademarks
Phoenix Pharma Polska holds 3 active trademarks registered with the Polish Patent Office. 13 marks have expired or were not registered. The first mark was filed in 1992.
| Mark | Protected until | |
|---|---|---|
| PHOENIX Pharma Polska Sp z. o. o. A company of PHOENIX group | Dec 29, 2034 | |
| PHARMA(word) | Jun 18, 2027 | |
| TRANSMED(word) | Jun 18, 2027 | |
| AKADEMIA DIABETYKA | – | |
| APTEKA DIABETYKA(word) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the event of the appointment of a multi-member management board, the company is represented by two members of the management board jointly, or by one member of the management board together with a commercial proxy. The company may be represented by two commercial proxies jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Phoenix International Holdings Gmbh | 15,000 | $4,051,863.86 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| AsclepiosS.A. | $291,166,555.86 | asclepios.pl | ||
| NovoS.A. | $209,522,261.96 | novo-sa.pl | ||
| PGD Polskasp. z o.o. | $179,311,590.64 | pgdpolska.pl | ||
| Przedsiębiorstwo Zaopatrzenia Aptek Multi PharmeS.A. | $146,864,520.79 | multipharme.pl | ||
| Tramcosp. z o.o. | $138,687,577.46 | tramco.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Medezinsp. z o.o. | $107,559,392.19 | medezin.pl | ||
| Magnapharm Polandsp. z o.o. | $90,512,785.67 | magnapharm.pl | ||
| Dospirosp. z o.o. | $67,870,706.01 | dospiro.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-11-20 | Address change (Opłotek 26, 01-940, Warszawa → Ul. Rajdowa 9, 05-850, Konotopa) | |
| 2014-12-30 | Share capital change (149,266,000.00 PLN → 15,000,000.00 PLN) | |
| 2012-02-28 | Address change (Baletowa 115 A, 02-867, Warszawa → Opłotek 26, 01-940, Warszawa) | |
| 2006-11-10 | Share capital change (113,000,000.00 PLN → 149,266,000.00 PLN) | |
| 2006-04-28 | Share capital change (76,000,000.00 PLN → 113,000,000.00 PLN) |
FAQ
Last updated: 2026-10-07